SCHEMBL23309578

SCHEMBL23309578

O=C(Nc1cccc(Cc2ccccc2)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PARP1 P09874 2/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ GAA P10253 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ HTT P42858 1/20 0.41
▸ PPARG P37231 2/20 0.41
▸ PPARD Q03181 2/20 0.41
▸ PPARA Q07869 2/20 0.41
▸ NR1H4 Q96RI1 2/20 0.41
▸ LRRK2 Q5S007 1/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309490 0.86 GAA (0.51) KMT2AMEN1SMN1; SMN2L3MBTL1KDM4E
SCHEMBL23309585 0.81 KDM4E (0.52) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT
SCHEMBL23309548 0.80 FADS1 (0.55) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT
SCHEMBL23309536 0.80 MEN1 (0.55) KMT2AMEN1SMN1; SMN2L3MBTL1KDM4E
SCHEMBL23309730 0.78 KMT2A (0.47) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL23309568 0.78 P2RX1 (0.59) KMT2AMEN1SMN1; SMN2MAPTGAA
SCHEMBL23309706 0.77 TSHR (0.55) KMT2ASMN1; SMN2L3MBTL1MAPTGAA
SCHEMBL23309501 0.77 FADS1 (0.56) KMT2AMEN1SMN1; SMN2RXFP1
SCHEMBL23309513 0.77 RAB9A (0.63) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL23309512 0.77 HTT (0.57) KMT2AMEN1SMN1; SMN2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL BCL2 3433/4885KMT2A 2360/4885MEN1 1633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback